Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000539615 | SCV000623329 | likely benign | Bloom syndrome | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001021816 | SCV001183481 | benign | Hereditary cancer-predisposing syndrome | 2019-10-04 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Sema4, |
RCV001021816 | SCV002533051 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-07-28 | criteria provided, single submitter | curation | |
Genome Diagnostics Laboratory, |
RCV001702499 | SCV001929233 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001702499 | SCV001964122 | likely benign | not provided | no assertion criteria provided | clinical testing |